Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > PDGFR > Linifanib(ABT-869; AL-39324; RG3635)

Linifanib(ABT-869; AL-39324; RG3635)

ChemLeader 99+%

Catalog No：CL2480 CAS No.：796967-16-3 MDLNo：MFCD11840918 Formula：C21H18FN5O MW：375.40

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	3-5days	$66.00	Visible after login	- +
10 mg	3-5days	$96.00	Visible after login	- +
25 mg	3-5days	$166.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Linifanib(ABT-869; AL-39324; RG3635)
CAS	796967-16-3
Formula	C21H18FN5O
MW	375.40
MDL	MFCD11840918
Appearance	White to gray powder

Product details

Linifanib (formerly RG3635, ABT869, AL39324) is an orally bioavailable and ATP-competitive inhibitor of multiple kinases (e.g. VEGFR/PDGFR) with potential antitumor activity. Its IC50 values are 4 nM, 3 nM, 3 nM/4 nM, and 66 nM for KDR, CSF-1R, Flt-1/3, and PDGFRβ, respectively. Linifanib has strong antitumor efficaciousness in vivo and outstanding anti-proliferative activity in vitro.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2480

Linifanib(ABT-869; AL-39324; RG3635)

796967-16-3 99+%